Logo image
Se connecter
Retour
The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans
Article de revue   Avec comité de lecture

The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans

Jacques Fantini, Christian A. Devaux, Nouara Yahi et Roger Frutos
The Journal of infection, Vol.84(5), pp.e53-e54
01/05/2022
DOI: https://doi.org/10.1016/j.jinf.2022.03.001
PMID: 35263637

Résumé

ACE2 COVID-19 Hong Kong humans SARS-CoV-2 Spike, selective advantage, hamsters
•The D427G mutation optimizes the ACE2 interaction.•The variant is adapted to hamsters.•The same variant is potentially favored on humans.•There is a risk of novel variant emergence.•This hamster-adapted variant must be monitored. [Display omitted]

Indicateurs

1 Consultations de la notice

Détails

Logo image